BIBLIOGRAFÍA

 

1.-BRIGDEN W. Uncommon myocardial disease. The noncoronary cardiomyopathies. Lancet 1957;2:1179-1243.

2.-FEJFAR Z. Accounts of international meetings. Idiopathic cardiomegaly. Bull WHO 1968;38:979-992.

3.-Report of the WHO/ISFC task force the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-673.

4.-ABELMANN WH. Classification and natural history of primary myocardial disease. Prog Cardiovasc Dis 1984;27:73-94.

5.-WYNNE J, BRAUNWALD E. The cardiomyopathies and myocarditides. En Heart Disease. A textbook of cardiovascular medicine. E. Braunwald Ed. WB Saunders Co. Philadelphia.1988.p:5

6.-TEARE RD. Asymetricalhypertrophy of the heart in young adults. Br Heart J 1958;20:1-8.

7.-SHAP PM, GRAMIAK R, KRAMER DH. Ultrasound location of the left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 1969;40:3-11.

8.-PRIDIE RB, OAKLEY CM. Mechanism of mitral regurgitation in hypertrophic obstructive cardiomyopathy. Br Heart J 1970;32:203-208.

9.-ABBASI AS, MACALPIN RN, EBER LM, PEARCE ML. Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 1972;46:897-904.

10.-SILVER MM, SILVER MD. Cardiomyopathies.En cardiovacular pathology. MD Silver ed. Churchill Livingstone. New York 1983. p:489-516.

11.-MARON BJ, GOTTDIENER JS, EPSTEIN SE. Echocardiographic identification of patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy. En Hypertrophic cardiomyopathy. M Kaltenbach y SE Epstein eds. Springer-Verlag. Berlin. 1982.p:192.

12.-KLUES HG, SCHIFFERS A, MARON BJ. Phenotypic spectrum and patterns of the left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations, and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-1708.

13.-SAKAMOTO T, TEI C, MURAYAMA M, et al. Gigant T walve inversion as a manifestation of aymemetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J, 1976;17:611-629.

14.-DAVIES MJ, WJ MCKENNA. Hypertrophic cardiomyopaty- pathology and pathogensis. Histopatology 1995;26:493-500.

15.-HENRY WL, CLARK CE, EPSTEIN S. Asymmetric septal hypertrophy (ASH): echocardiographic identification of the pathonogmonic anatomic abnormality of IHSS.Circulation 1973;47:225-233.

16.-MARON B, EPSTEIN SE. Hypertrophic cardiomyopathy. recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol 1980;45:141-154.

17.- MCKENNA WJ, STEWART JT, NIHOYANNOPOULOS P, et al. Hypertrophic cardiomyopathy without hypertrophy:2 families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990;63:287-290.

18.-YUTANI C, IMAKITA M, ISHIBASHI-UEDA H, et al. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic myocardiopathy. Am Heart J. 1985,109,545-553.

19.- KLUES HG, ROBERTS WC, MARON JB. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Circulation 1991;84:1188-1197.

20.-COHEN J, EFFAT H, GOODWING JF, et al. Hypertrophic obstructive cadiomyopathy.Br Heart J 1964; 26:16.

21.-WIGLE ED, ADELMAN AG, AUGER P, MARQUIS Y. Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 1969;24:698-706.

22.-HUTCHINS GM, BULKLEY BH. Catenoid shape of the interventricular septum: Possible cause of idiopathic hypertrophic subaortic stenosis. Circulation 1978;58:392-397.

23.-GOODWIN JF. Prospects and predictions for the cardiomyopathies. Circulation 1974;50:210-219.

24.-MARON BJ, ROBERTS WC. Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revised: relation between the two and significance.Am Heart J 1981,102,95-110.

25.-SOMERVILLE J, BECU L. Congenital heart disease associated with hypertrophic cardiomyopathy. Br Heart J 1978;40:1034-1039.

26.-VAN DER BEL-KAHN J. Muscle fiber disarray in common heart disease. Am J Cardiol 1977;40:355-364.

27.-BULKLEY BH, WEISFELDT ML, HUTCHINS GM: Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts. Circulation 1977, 56,292-298.

28.-DAVIES MJ. The cardiomyopathies. En The pathology of the heart. A Pomerance y MJ Davies eds. Blackwell Scientific Pub. Oxford.1975. p:221.

29.-MARON BJ, ROBERTS WC. Distribution and significance of cardiac muscle cell disorganization in the left ventricle of patients with hypertrophic cardiomyopathy: Evidence of a diffuse cardiomyopathic process. En Hypertrophic cardiomyopathy. M Kaltenbach y E Epstein eds. Springer-Verlag.Berlin.1982. p:38-57.

30.-FRANCALANCI P, GALLO P, BERNUCCI P, et al. The pattern of desmin filaments in myocardial disarray. Hum Pathol 1995;26:262-266.

31.-MARON BJ, WOLFSON JK, EPSTEIN SE, ROBERTS WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.

32.-JAMES TN, MARSHALL TK. De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart. Circulation 1975;51:1149- 1166.

33.-BRAUNWALD E, MORROW AG, CORNELL WP et al. Idiopathic hypertrophic subaortic stenosis. Am J Med 1960;29:924-945.

34.-WIGLE ED, HEIMBECKER RO, GUNTON RW. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 1962;26:325-340.

35.-BJARNASON I, JONSSON S, HARDARSON T. Mode of inhertance of hypertrophic cardiomyopathy in Iceland echocardiographic study. Br Heart J 1982;47:109-112.

36.-DAVIES MJ, KRIKLER DM. Genetic investigation and comselling of families with hypertrophic cardiomyopathy. Br Heart J 1994;72:99-101.

37.-WATKINS H. Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J 1994;72:4-9.

38.-WATKINS, ANAN K, COVIELLO DA, et al. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyiopathy. Circulation 1995;91:2302-2305.

39.- MARIAN AJ. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers. Clin Cardiol 1995;18:189-198.

40.-GOODWIN JF. congestive and hypertrophic cardiomyopathies: a decade of study. Lancet 1970;1:731-739.

41.-BOUHOOR JB, LANGLARD JM,. Dysfonction ventriculaire systolique dans les myocardiopathies. Arch Mal Coeur Vaiss 1996;89(Spec 2):33-37.

42.-CODD MB,SUGINE DD,GERSH BJ,MELTON LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 1989;80:564-572.

43.-MICHELS VV, MOLL PP, MILLER F, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.

44.-GOERS JB, MICHELS VV, BURNETT J, et al. Frequency of familial dilated cardiomyopathy. Eur Heart J 1996;16(suppl O):2-4.

45.-RAMPAZZO A, NAVA A, DANIELI GA et al. The gene for arrhytmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994;3:959-962.

46.-DURAND JB, BACHINSKI LL, BIELINGS LC et al. Localization of a gene responsible for familial dilated cardiomyopathy to chromodome 1q32. Circulation 1995;92:3387-3389.

47.-ROBERTS WC, SIEGEL RJ, McMANUS BM. Idiopathic dilated cardiomyopathy: Analysis of the 152 necropsys patients. Am J Cardiol 1987;60:1340-1355.

48.-FUSTER V, GERSH BJ,GUILIANI ER et al. The natural history of idiopathic dilated cardiomyopathy. Am J cardiol 1981;4:525-530.

49.-OLSEN EGJ. Pathology, causes and relation to myocarditis. En Heart muscle disease. JF Goodwin ed. MTP Press Limited. Avon.1985 pag:57-74.

50.-DAVIES MJ. The cardiomyopathies: a review of terminology, pathology and pathogenesis. Histopathology 1984;8:363-393.

51.-ROBERTS WC, FERRANS VJ. Pathologic anatomy of the cardiomyopathies: idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial didease with and without eosinophilia. Hum Pathol 1975;6:287-342.

52.-OLSEN EGJ.Postmortem finding and histologic, histochemical, and electron microscopic finding of myocardial biopsies. En cardiomyopathy and myocardial biopsy. M Kaltenbach, F Loogen y EGJ Olsen. Spriger-Verlag. Berlin. 1978. p:52-61.

53.-JOHNSON RA, PALACIOS I. Dilated cardiomyopathies of the adult. N Engl Med 1982;307:1051-1058.

54.-URIE PM, BILLINGHAM ME. Ultrastructural features of familial cardiomyopathy. Am J Cardiol 1988:62:325-327.

55.-SHAH KD, DXINI BV. Non invasive and invasive evaluation of left bundle branch block (LBBB). Acta Cardiol 1990;45:125-131.

56.-SCHWARZ F, MALL G, ZABE H, et al. Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:501-506.

57.-NAKAYAMA Y, SHIMIZU G, HIROTA Y, et al. Functional and histopathologic correlation in oatients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 1987:10;186-192.

58.-MARIJANOWSKI M, TEELING P, MANN J, BECKER AE. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assesment. J Am Coll Cardiol 1995;25:1263-1272.

59.-GRUJA-SMITH Z, MORALES AR, ROMANELLI R, WOESSNER JF. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Am J Pathol 1996;148:1639-1648.

60.-BELTRAMI CA, DELLA MEA V, FINATO N, ROCCO M. Computer-assisted morphometric analysis of the heart. Anal Quant Cytol Histol 1996;18:129-136.

61.-AGAPITOS E, KAVANTZAS N, NANAS J, et al. The myocardial fibrosis in patients with dilated cardiomyopathy. the application of image analysis in the myocardila biopsies. Gen Diagn Pathol 1996;141:305-311.

62.-GALLO P, D'AMATI G, PELLICIA F, et al. Functional significance of myocellular hypertrophy in dilated cardiomyopathy: histomorphometric analysis on 40 endomyocardial biopsies. Am J Cardiovasc Pathol 1995;5:11-18.

63.-SHANES JG, GHALI J, BILLINGHAM E, et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 1987;75:401-405.

64.-BOUHOUR JB, HELIAS J, LAJARTRE AY, et al. Detection of myocarditis during the first year after discovery of dilated cardiomyopathy by endomyocardial biopsy and Gallium-67 myocardial scintigraphy: prospective multicentre trench study of 91 patients.Eur Heart J 1988;9:520-528.

65.-HUHL V, NOUTSIAS M, SEEBERG B, SCHULTHEISS HP. Inmunohistological evidence for a chronic intramyocardial inflamatory process in dilated cardiomyopathy. Heart 1996;75:295-300

66.-NARULA J, HAIDER N, VIRMANI R et al. Apoptosis in myocites in end-stage heart failure. N Engl J Med 1996;335:1182-1189

67.- INO T, NISHIMOTO K, OKUBO M, et al. Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol 1997;79:1137-1141.

68.-MARCUS FI, FONTAINE GH, QUIRAVALON G et al. Right ventricular dysplasia: a repot of 24 adult cases. Circulation 1982;65:384-398

69.-MCKENNA WJ, THIENE G, NAVA A, et al. Diagnosis of arrhytmogenic right ventricular dysplasia/cadiomyopathy. Br Heart J 1994;71:215-218.

70.-PINAMONTI B, SINAGRA G, DILENARDI A, et al. Left ventricular involvement in right ventricular cardiomyopathy. Postgrad Med J 1992;68 (suppl 1);s36-s39.

71.-LOFFLER W. Endocarditis parietalis fibroplastica mit bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz Med Wochenschr 1936;18:817-820.

72.-DAVIES JNP, BALL JD. The pathology of endomyocardial fibrosis in Uganda. Br Heart J 1955;17337-359.

73.-BROCKINGTON IF, OLSEN EGJ. Löffler's endocarditis and Davies' endomyocardial fibrosis.Am Heart J 1973;85:308-322.

74.-OLSEN EGJ, SPRY CJF. Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 1985;27:241-254.

75.-DAVIES J, SPRY CJF, VIJAYARAGHAVAN G, SOUZA JA. A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions Postgrad Med J 1983;59:51-55.

76.-BENOTTI JR, GROSSMAN W, COHN PF. Clinical profile of restrictive cardiomyopathy. Circulation 1980;61:1206-1212.

77.-GOODWING JF. Endomyocardial disease:clinical features. Postgrad Med J 1983;59:154-155.

78.-GRAVANIS MB, ANSARI AA. Idiopathic cardiomyopathies. Arch Pathol Lab Med 1987;111:915-929.

79.-OLSEN EGJ. Cardiomyopathies. Cardiovasc Clinics 1972;4:240- 261.

80.-OLSEN EGJ. Loffler's endocarditis and myocardial fibrosis. Pathol Microbiol 1975;43:104-106.

81.-ROBERTS WC, BUJA LM, FERRANS VJ. Loffler's fibroplastic parietal endocarditis, eosinophilic leukemia and Davies' endomyiocardial fibrosis the same disease at different stages. Pathol microbiol 1970;35:90-95.

82.-SIEGEL RJ, SHAH PK, FISHBEIN MC. Idiopathic restrictive cardiomyopathy. Circulation 1984;70:165-169.

83.-WEISS-CARMINE S. Die Endocarditis parietalis fibroplastica mit Bluteosinophilie (Loffler) und ihre Stellung im Rahmen der Parietalendokardfibrosen. Schweiz Med Wochenschr 1957;87:890-898.

84.-OLSEN EGF. Pathological aspects of endomyocardial fibrosis. Postgrad Med J 1983;59:135-139.

85.-SCHOENFELD MH, SUPPLE EW, DEC GW, et al. Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecesary thoracotomy. Circulation 1987;75:1012-1017.

86.-VAITKUS PT, KUSSMAUL WG. Constrictive pericarditis versus restrictive cardiomyopathy: a reappraisal and update of diagnostic criteria. AM Heart J 1991,122:1431-1441.

87.-BOFFA GM, THIENE G, NAVA A, DALLA VOLTA S. Cardiomyopathy:a necessary revision of the who classification. Int J Cardiol 1991;30:1-7.

88.-D'ORAZIO G, TULLIO D, RASETTI G, et al. Cardiomiopatia restrittiva idiopatica. Descrizione de 4 casi. Minerva Cardioangiol 1990;38:541-546.

89.-HIROTA Y, SHIMIZU G, KITA Y, et al. Spectrum of restrictive cardiomyopathy:report of the national survey in Japan. Am Heart J 1990;120:188-194.

90.-KATRITSIS D, WILMSHURST PT, WENDON JA, et al. Primary restrictive cardiomyopathy: clinical and patholgic characteristics. J Am Coll Cardiol 1991;18:1230-1235.

91.-BACKES RJ, GERSH B. Cardiomyopathies in the elderly. Cardiovasc Clin 1992;22:105-125.

92.-LEWIS AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 1992;123:1589-1593

93.-CETTA F, O'LEARY PW, SEWARD JB, DRISCOLL DJ. Idiopathic restrictive cardiomyopathy in childhood. diagnosis features and clinical course. Mayo Clin Proc 1995;70634-640.

94.-SANTOS J, GONZALEZ A, BARRENA ML, et al. Miocardiopatia restrictiva en el niño. Estudio de cuatro pacientes. An Esp Pediatr 1996;44:192-202.

95.-GANDHI VK, DALAL SB, SHARMA JR, et al. Cardiomyopathy in children in Ahmedabad. India J Pediatr 1991;58:665-670